When it comes to your dog’s well-being, few things are as unsettling as a health condition. Immune-mediated polyarthritis (IMPA) is one such ailment that can affect multiple joints in your dog, causing discomfort and affecting their quality of life.

This guide aims to be your go-to resource for understanding immune-mediated polyarthritis in dogs, offering crucial insights into its diagnosis, treatment options, and management. With the right knowledge, you can take proactive steps to ensure your dog lives a comfortable and fulfilling life.

Keep reading to learn more. 

What is Immune-mediated polyarthritis?

Immune-mediated polyarthritis is a condition that poses a significant health concern for dogs. The term ‘immune-mediated’ is indicative of the role the immune system plays in this disorder. Polyarthritis is a medical term that refers to the inflammation of five or more joints. Unlike osteoarthritis, a degenerative disease that wears down joints over time, IMPA is an inflammatory condition that can affect multiple joints simultaneously.

This misguided immune response leads to inflammation, causing pain and discomfort in the affected joints. IMPA can manifest as either idiopathic, meaning its cause is unknown, or secondary to other underlying conditions such as infections, cancer, or drug reactions.

Types of Immune-Mediated Polyarthritis

Understanding the types of IMPA can help in better management and treatment of the condition. It is categorised into two primary forms: erosive and non-erosive.

1. Erosive: Erosive IMPA is the more severe form of the condition. It not only causes inflammation but also leads to the erosion or destruction of the cartilage within the joint. This erosion can result in permanent joint damage, affecting the dog’s mobility and quality of life. Erosive IMPA is less common but requires aggressive treatment to stop the progression of joint damage.
2. Non-erosive: Non-erosive IMPA is characterised by inflammation of the synovial membrane without the erosion of cartilage or other joint structures. Although considered less severe than its erosive counterpart, non-erosive IMPA still requires immediate medical intervention. Left untreated, the inflammation can lead to other complications and significantly impair the dog’s movement and comfort.

Always consult a vet for a comprehensive evaluation if you suspect your dog is suffering from IMPA.

Common Causes

As previously mentioned, the root cause of IMPA lies within your dog’s immune system. While the immune system is designed to ward off infections, it’s crucial to understand that IMPA is not a result of an infection within the joints. 

Quite the contrary, in all cases of IMPA, there are no infections within the joints at all, meaning that a trigger elsewhere in the body activates the immune system, kickstarting the antibody response. Those antibodies enter the joint via the joint fluid and begin a chemical reaction that leads to the swelling of the joint.

Potential Triggers for IMPA

Understanding the potential triggers for IMPA can aid in early diagnosis and effective management. While an infection in another part of the body can be a culprit, IMPA can also be triggered by a variety of other factors, some of which are:

• Physical Injuries: Trauma or injury to a joint or surrounding tissue can set off an immune response, potentially leading to IMPA. Even a minor injury can sometimes be enough to trigger this condition.
• Medications: Certain medications, particularly antibiotics and some anti-inflammatory drugs have been known to induce IMPA. Always consult your vet about the potential side effects of any medication your dog is taking.
• Vaccinations: Though rare, there have been instances where vaccinations have triggered IMPA. It’s a controversial topic that requires more research, but one that can’t be entirely ruled out.
• Cancers: Malignancies elsewhere in the body can provoke an immune response strong enough to trigger IMPA. In such cases, treating the underlying cancer is crucial.
• Systemic Lupus Erythematosus: Systemic Lupus Erythematosus (SLE) affects multiple systems in the body and can lead to joint inflammation among other symptoms. This autoimmune disease can also be a trigger for IMPA. 
• Breed-Specific Susceptibility: Certain breeds, such as Akitas, have shown a higher predisposition to developing IMPA. While the reasons for this are not entirely clear, genetics likely play a significant role.

Diagnosing Immune-Mediated Polyarthritis in Dogs

Early diagnosis is not just beneficial – it’s essential for the effective treatment and management of IMPA. The sooner you catch it, the better the chances of managing the symptoms and preventing further joint damage, thereby giving your dog an opportunity to have a better quality of life.

1. Veterinary Examination: The first step is a comprehensive physical examination by a qualified vet. This initial assessment will provide a baseline understanding of your dog’s condition and guide further diagnostic tests.
2. Blood Tests: Blood tests are essential to rule out other conditions that may mimic the symptoms of IMPA. These tests can include a complete blood count and biochemistry profile, among others.
3. X-rays and Ultrasound: Imaging studies like X-rays and ultrasound offer a detailed view of the affected joints. While these tests won’t confirm IMPA, they can rule out other joint conditions such as fractures or degenerative diseases.
4. Joint Fluid Analysis: A definitive diagnosis of IMPA often hinges on joint fluid analysis. This test involves taking a sample of the fluid within the affected joint(s) and analysing it for signs of inflammation and other abnormalities.

Diagnosing IMPA is a multi-step process that requires a thorough veterinary examination and a series of diagnostic tests. 

Clinical Signs

The signs of IMPA can vary significantly, especially if it develops secondary to another medical condition. It’s crucial to understand that your dog may not exhibit all of these symptoms, making diagnosis challenging. If you observe any behavioural changes in your pet, consult a vet as soon as possible.

Common signs to watch out for include:

General Fatigue

Your dog may seem less energetic than usual, showing a general sense of fatigue and disinterest in activities they once enjoyed.

Fever

A persistent elevated body temperature is a red flag and should prompt immediate veterinary consultation.

Reduced Appetite and Weight Loss

A noticeable reduction in appetite often accompanies IMPA, which can lead to weight loss if not addressed promptly.

Reluctance to Move

Your dog may seem hesitant to move, particularly after resting. This reluctance can be a sign of joint discomfort.

Limping or Lameness

Limping or an uneven gait is often one of the more visible signs of IMPA. This symptom usually indicates that the condition has affected multiple joints.

Stiffness in Joints

Stiff, rigid joints can make it difficult for your dog to move freely, affecting their quality of life.

Joint Swelling and Discomfort

Swollen, inflamed joints are a sign of IMPA. The swelling can be subtle or quite noticeable, depending on the severity of the condition.

Treatment Options for Immune-Mediated Polyarthritis

Managing IMPA is a long-term commitment that requires a varied approach. The primary aim is to suppress the dog’s immune system’s overactive response, thereby alleviating the symptoms and preventing further joint damage.

Immunosuppressive Drugs

The cornerstone of IMPA treatment is immunosuppressive medication. These drugs are often administered at a higher initial dose to quickly control the inflammation, followed by a tapered dose over an extended period. It’s imperative that your vet rules out other forms of arthritis before initiating this treatment, as immunosuppressive drugs can exacerbate other types of arthritis.

Stem Cell Therapy

Stem cell therapy is an emerging treatment option. It involves harvesting stem cells, usually from the dog’s own tissue, and injecting them into the affected joints. The stem cells have the potential to reduce inflammation and promote tissue repair, offering a less invasive alternative to traditional treatments. Studies and research indicate that stem cell therapy can significantly reduce joint inflammation as well as improve both mobility and quality of life for dogs affected with arthritis but treatment for immune mediated polyarthritis is still awaiting clinical trials and is not considered a treatment option at the time of writing.  

Medication

Corticosteroids and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are commonly used in conjunction with immunosuppressive drugs. These medications help manage pain and inflammation but must be used carefully to minimise potential side effects.

Physiotherapy

Physiotherapy for dogs can be a valuable adjunct to medical treatment. Exercises and stretches designed by a certified canine physiotherapist can improve joint function.

Prognosis

The prognosis for dogs with immune-mediated polyarthritis is variable and hinges on several factors, including the underlying cause and how well your dog responds to treatment. It’s crucial to note that ongoing monitoring is essential to assess the effectiveness of the treatment and to make necessary adjustments. 

Regular vet check-ups will include blood tests and possibly imaging studies to ensure that the treatment is not causing any adverse effects. However, with timely and effective treatment, many dogs can lead a fulfilling, comfortable life.

Key Takeaways

Navigating IMPA in dogs requires a comprehensive approach to diagnosis, treatment, and long-term management.

Early detection is key, as it allows for prompt intervention to manage symptoms and prevent further joint damage. Treatment must be tailored to each individual dog, ranging from immunosuppressive drugs to emerging options like stem cell therapy. Ongoing care involves regular veterinary check-ups, dietary adjustments, and a focused pain management strategy.

With timely and effective treatment, many dogs can manage their symptoms and maintain a good quality of life. Contact our vets at Stem Cell Vet for more information on stem cell therapy.